Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial

CardioVascular and Interventional Radiology, vol. 46, pp. 350–359

Authors 16

1. Thaïs M. L. Tong Aachen Department of Medical Oncology Department of Radiology, Leiden University Medical Center

   Leiden University Medical Center

   Affiliation as printed

   Department of Medical Oncology, Leiden University Medical Center, Postal Zone C7-P, Albinusdreef 2, 2333ZA, Leiden, The Netherlands

   Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands

2. Mark Christiaan Burgmans Aachen Department of Radiology, Leiden University Medical Center

   Leiden University Medical Center

   Affiliation as printed

   Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands

3. Frank M. Speetjens Aachen Department of Medical Oncology

   Leiden University Medical Center

   Affiliation as printed

   Department of Medical Oncology, Leiden University Medical Center, Postal Zone C7-P, Albinusdreef 2, 2333ZA, Leiden, The Netherlands

4. Arian R. van Erkel Aachen Department of Radiology, Leiden University Medical Center

   Leiden University Medical Center

   Affiliation as printed

   Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands

5. Rutger W. van der Meer Aachen Department of Radiology, Leiden University Medical Center

   Leiden University Medical Center

   Affiliation as printed

   Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands

6. Catherina S. P. van Rijswijk Aachen Department of Radiology, Leiden University Medical Center

   Leiden University Medical Center

   Affiliation as printed

   Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands

7. M. A. Jonker-Bos Aachen Department of Medical Oncology

   Leiden University Medical Center

   Affiliation as printed

   Department of Medical Oncology, Leiden University Medical Center, Postal Zone C7-P, Albinusdreef 2, 2333ZA, Leiden, The Netherlands

8. C. F. M. Roozen Aachen Department of Medical Oncology

   Leiden University Medical Center

   Affiliation as printed

   Department of Medical Oncology, Leiden University Medical Center, Postal Zone C7-P, Albinusdreef 2, 2333ZA, Leiden, The Netherlands

9. M. Sporrel-Blokland Aachen Department of Medical Oncology

   Leiden University Medical Center

   Affiliation as printed

   Department of Medical Oncology, Leiden University Medical Center, Postal Zone C7-P, Albinusdreef 2, 2333ZA, Leiden, The Netherlands

10. Jacob Lutjeboer Aachen Department of Radiology, Leiden University Medical Center

    Leiden University Medical Center

    Affiliation as printed

    Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands

11. Els L. van Persijn van Meerten Aachen Department of Radiology, Leiden University Medical Center

    Leiden University Medical Center

    Affiliation as printed

    Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands

12. Chris H. Martini Aachen Department of Anesthesiology, Leiden University Medical Center

    Leiden University Medical Center

    Affiliation as printed

    Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands

13. Remco W. M. Zoethout Aachen Department of Anesthesiology, Leiden University Medical Center

    Leiden University Medical Center

    Affiliation as printed

    Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands

14. Fred G. J. Tijl Aachen Department of Extra Corporal Circulation

    Leiden University Medical Center

    Affiliation as printed

    Department of Extra Corporal Circulation, Leiden University Medical Center, Leiden, The Netherlands

15. Christian U. Blank Aachen Department of Medical Oncology

    Leiden University Medical Center · The Netherlands Cancer Institute

    Affiliation as printed

    Department of Medical Oncology, Leiden University Medical Center, Postal Zone C7-P, Albinusdreef 2, 2333ZA, Leiden, The Netherlands

    Department of Medical Oncology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek Hospital, Amsterdam, The Netherlands

16. Ellen Kapiteijn corresponding Aachen Department of Medical Oncology

    Leiden University Medical Center

    Affiliation as printed

    Department of Medical Oncology, Leiden University Medical Center, Postal Zone C7-P, Albinusdreef 2, 2333ZA, Leiden, The Netherlands. h.w.kapiteijn@lumc.nl

    Department of Medical Oncology, Leiden University Medical Center, Postal Zone C7-P, Albinusdreef 2, 2333ZA, Leiden, The Netherlands